Lorenzo Cohen

Last updated

Lorenzo Cohen is a professor in the Department of General Oncology and Behavioral Science and the director of the Integrative Medicine Program at the University of Texas MD Anderson Cancer Center. He is also a distinguished clinical professor at the Fudan University Shanghai Cancer Center in Shanghai, China.[ citation needed ] Cohen is a founding member and past president of the Society for Integrative Oncology.

Contents

Cohen has been involved with numerous studies examining psychosocial and integrative medicine interventions to improve quality of life and outcomes for patients with cancer [1] and other serious diseases, including therapies such as reiki, "energy medicine", acupuncture, and yoga. [2] [3] David Gorski has called the topics of Cohen's research quackery and a waste of taxpayer dollars; he has criticized Cohen for taking a credulous stance on pseudoscience. [4] His directorship of integrative medicine at MD Anderson Cancer Center has been criticized for offering ineffective treatments to patients. [5]

Education

Cohen earned a B.A. degree in psychology from Reed College in 1987. He received an M.S. degree in medical psychology from the Uniformed Services University of the Health Sciences in 1993 having completed a thesis entitled The Effects of Cocaine and Stress on Lymphocyte Proliferation in Rats. [6] Cohen then obtained his Ph.D. degree in medical and clinical psychology from the same school in late 1994 having completed a doctoral thesis entitled The Efficacy of Preparation, Distraction, and Information, on Decreasing the Stress Response. [7] In both cases, his primary advisor was Andrew S. Baum.

Career

Cohen was awarded a Postdoctoral Research Fellowship from the National Cancer Institute of Canada. Since then, he has received continual research support from the National Cancer Institute, National Institutes of Health, United States in the form of R01 funding, with up to four R01's funded at a time. In 2007, he became a Distinguished Clinical Professor of Fudan University Cancer Hospital, where he continues his research on traditional Chinese medicine that started in 2003. In 2007, Cohen earned the International Scientific and Technological Cooperation Award [8] of Shanghai Municipality.

In 2008, the Shanghai Municipal People's Government awarded Cohen the Silver Magnolia Memorial Award [9] and in 2011 the Gold Magnolia Memorial Award, in recognition of outstanding contributions to the city of Shanghai. In 2011, Cohen was recognized by the Society for Integrative Oncology with the Outstanding Achievement Award. Cohen is a Fellow of the Academy of Behavioral Medicine Research.

Published works

Cohen has published extensively in the field of integrative therapies in oncology and beyond.

Books

Original reports

Book chapters

Related Research Articles

Nicholas J. Vogelzang was a medical oncologist with Comprehensive Cancer Centers of Nevada (CCCN). He serves as Medical Director of the Research Executive Committee and Associate Chair of the Developmental Therapeutics and Genitourinary Committees for US Oncology Research. His research interests include clinical trials for genitourinary malignancies and mesothelioma.

<span class="mw-page-title-main">Yoga as therapy</span> Yoga in the use of physical and mental therapy

Yoga as therapy is the use of yoga as exercise, consisting mainly of postures called asanas, as a gentle form of exercise and relaxation applied specifically with the intention of improving health. This form of yoga is widely practised in classes, and may involve meditation, imagery, breath work (pranayama) and calming music as well as postural yoga.

<span class="mw-page-title-main">Cancer survivor</span> Person with cancer who is still alive


A cancer survivor is a person with cancer of any type who is still living. Whether a person becomes a survivor at the time of diagnosis or after completing treatment, whether people who are actively dying are considered survivors, and whether healthy friends and family members of the cancer patient are also considered survivors, varies from group to group. Some people who have been diagnosed with cancer reject the term survivor or disagree with some definitions of it.

<span class="mw-page-title-main">Alternative cancer treatments</span> Alternative or complementary treatments for cancer that have not demonstrated efficacy

Alternative cancer treatment describes any cancer treatment or practice that is not part of the conventional standard of cancer care. These include special diets and exercises, chemicals, herbs, devices, and manual procedures. Most alternative cancer treatments do not have high-quality evidence supporting their use and many have been described as fundamentally pseudoscientific. Concerns have been raised about the safety of some purported treatments and some have been found unsafe in clinical trials. Despite this, many untested and disproven treatments are used around the world. Promoting or marketing such treatments is illegal in most of the developed world.

Rakesh K. Jain is the Andrew Werk Cook Professor of Tumor Biology at Massachusetts General Hospital in the Harvard Medical School and Director of the E.L. Steele Laboratories for Tumor Biology at the Massachusetts General Hospital.

<span class="mw-page-title-main">Steven Libutti</span> American surgeon and scientist

Steven Kenneth Libutti, M.D., F.A.C.S. is an American surgeon and scientist. In January 2017, he became the third permanent Director of the Rutgers Cancer Institute of New Jersey, Vice Chancellor for Cancer Programs for Rutgers Biomedical and Health Sciences and the Senior Vice President for Oncology Services for RWJBarnabas Health, the largest health system in New Jersey. He is a tenured Professor of Surgery at the Rutgers Robert Wood Johnson Medical School. Libutti's work on the study of tumor angiogenesis and the tumor microenvironment has led to novel approaches for the treatment of cancer. He is also one of the pioneers of regional and targeted cancer therapy.

Barrie Joyce Rabinowitz Cassileth was an American medical sociologist and researcher of complementary medicine and a critic of alternative medicine. She published extensively on alternative cancer treatments.

Karol Sikora is a British physician specialising in oncology, who has been described as a leading world authority on cancer. He was a founder and medical director of Rutherford Health, a company that provided proton therapy services, and is Director of Medical Oncology at the Bahamas Cancer Centre.

<span class="mw-page-title-main">Hans Alfred Nieper</span>

Hans Alfred Herbert Eugen Nieper was a controversial German alternative medicine practitioner who devised "Nieper Therapy". He is best known for his claims to be able to treat cancer, multiple sclerosis, and other serious diseases. His therapy has been discredited as ineffective and unsafe.

<span class="mw-page-title-main">Hope & Heroes Children's Cancer Fund</span> Non-profit organisation in the US

Hope & Heroes is a 501(c)(3) non-profit organization based at Columbia University Medical Center (CUMC) in New York City. Hope & Heroes supports the Division of Pediatric Hematology, Oncology & Stem Cell Transplantation at Columbia University Medical Center. Hope & Heroes funds work on childhood cancer and blood disorders at Columbia University Medical Center—including research, support for families, and care.

Catherine (Kate) Elizabeth Ulbricht is a co-founder of the Natural Standard Research Collaboration. She is a Senior Attending Pharmacist at Massachusetts General Hospital. She serves on the editorial board of Harvard Health Publications, the Journal of the American Nutraceutical Association, and Pharmacy Practice News. She is editor in chief of the Journal of Dietary Supplements.

Simon J. Hall, M.D., is the Associate Professor and Kyung Hyun Kim, M.D. Chair of Urology and Assistant Professor, Department of Gene and Cell Medicine at The Mount Sinai School of Medicine, as well as the Director of the Barbara and Maurice Deane Prostate Health and Research Center at The Mount Sinai Medical Center, both in New York City.

Otis Webb Brawley is an American physician and the Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University. He served as Chief Medical and Scientific Officer and Executive Vice President of the American Cancer Society from July 2007 to November 2018. He is board certified in internal medicine and medical oncology and is a Master of the American College of Physicians, Fellow of the American Society of Clinical Oncology, and a Fellow of the American College of Epidemiology. He is a member of the Institute of Medicine now known as the National Academy of Medicine.

<span class="mw-page-title-main">David Gorski</span> Science-based medicine advocate

David Henry Gorski is an American surgical oncologist, professor of surgery at Wayne State University School of Medicine, and a surgical oncologist at the Barbara Ann Karmanos Cancer Institute, specializing in breast cancer surgery. He is an outspoken skeptic, and a critic of alternative medicine and the anti-vaccination movement. He is the author of the blog Respectful Insolence, and the managing editor of the website Science-Based Medicine.

Dr. Kodaganur S. Gopinath, MS, FAMS, FRCS (Edin) is an Indian surgical oncologist, known for his pioneering work on oncological research. He is a recipient of many awards including Dr. B. C. Roy Award, considered to be the premier medical honour in the country. The President of India recognised his services to the field of oncology, by awarding him the fourth highest civilian award, Padma Shri, in 2010.

Lea Baider, is a professor of medical psychology, and considered one of the founders of psycho-oncology. She is the director of psycho-oncology at the Sharsheret Institute of Oncology at the Hadassah Medical Center in Jerusalem. Baider is also a member of the Middle East Cancer Consortium. Baider runs workshops in psycho-oncology to expand the field.

Bradley J. Monk is an American gynecologic oncologist, academician and researcher. He is a Professor on the Clinical Scholar Track in the Department of Obstetrics and Gynecology at the University of Arizona College of Medicine in Phoenix, Arizona, as well as at the Creighton University School of Medicine in Omaha, Nebraska. He also serves as Director of the Division of Gynecologic Oncology at the St. Joseph's Hospital and Medical Center in Phoenix.

References

  1. Enayati, Amanda (26 April 2012). "Searching for a medical miracle". CNN . Retrieved 27 July 2016.
  2. "Integrative oncology combines conventional, CAM therapies". Healio. 25 July 2010. Retrieved 26 July 2016.
  3. Reinberg, Steven. (December 27, 2019). "Acupuncture May Ease a Common Side Effect of Cancer Treatment" U.S. News & World Report . Retrieved April 16, 2020.
  4. Gorski, David (16 August 2010). ""Integrative" oncology: Trojan horse, quackademic medicine, or both? « Science-Based Medicine". Science-Based Medicine. Retrieved 18 June 2016.
  5. Salzberg, Steven (11 February 2013). "Bad Medicine Infiltrates MD Anderson Cancer Center". Forbes. Retrieved 26 July 2016.
  6. Commencement Exercises. Bethesda, Maryland: The Uniformed Services University of the Health Sciences. 15 May 1993. Retrieved 27 June 2021.
  7. Commencement Exercises. Bethesda, Maryland: The Uniformed Services University of the Health Sciences. 20 May 1995. Retrieved 27 June 2021.
  8. "International Scientific and Technological Cooperation Award". Archived from the original on 2015-04-14.
  9. "Shanghai Silver Magnolia Memorial Award". Archived from the original on 2015-04-14.
  10. "Yoga Helped Women with Breast Cancer Feel Better | dailyRx". Archived from the original on 2015-04-02. Retrieved 2015-03-30.
  11. http://ict.sagepub.com/content/9/4/348.full.pdf [ bare URL PDF ]
  12. Parker, Patricia A.; Pettaway, Curtis A.; Babaian, Richard J.; Pisters, Louis L.; Miles, Brian; Fortier, Adoneca; Wei, Qi; Carr, Danielle D.; Cohen, Lorenzo (2009). "The Effects of a Presurgical Stress Management Intervention for Men with Prostate Cancer Undergoing Radical Prostatectomy". Journal of Clinical Oncology. 27 (19): 3169–3176. doi:10.1200/JCO.2007.16.0036. PMC   2716938 . PMID   19349551.
  13. "CancerQuest | Depression". Archived from the original on 2015-04-02. Retrieved 2015-03-30.
  14. Cohen, Lorenzo; Cole, Steven W.; Sood, Anil K.; Prinsloo, Sarah; Kirschbaum, Clemens; Arevalo, Jesusa M. G.; Jennings, Nicholas B.; Scott, Shellie; Vence, Luis; Wei, Qi; Kentor, Diane; Radvanyi, Laszlo; Tannir, Nizar; Jonasch, Eric; Tamboli, Pheroze; Pisters, Louis (2012). "Depressive Symptoms and Cortisol Rhythmicity Predict Survival in Patients with Renal Cell Carcinoma: Role of Inflammatory Signaling". PLOS ONE. 7 (8): e42324. Bibcode:2012PLoSO...742324C. doi: 10.1371/journal.pone.0042324 . PMC   3409855 . PMID   22870317.